Review of (90)Y-ibritumomab tiuxetan as first-line consolidation radio-immunotherapy for B-cell follicular non-Hodgkin’s lymphoma

Christos Emmanouilides

Cancer Management and Research 2009, 1:131-136

Published Date: 21 October 2009